Holoprosencephaly - NOT chromosomal
Gene: SMAD2EnsemblGeneIds (GRCh38): ENSG00000175387
EnsemblGeneIds (GRCh37): ENSG00000175387
OMIM: 601366, Gene2Phenotype
SMAD2 is in 9 panels
3 reviews
Louise Daugherty (Genomics England Curator)
As discussed with the GMS Neurology Specialist Test Group webex call 11th July 2019: The Specialist Test Group all agreed that there is only enough evidence to rate this gene RedCreated: 29 Jul 2019, 2:16 p.m. | Last Modified: 29 Jul 2019, 2:16 p.m.
Panel Version: 1.20
Helen Brittain (Genomics England Curator)
Comment when marking as ready: PMID 18538293 assessed for variants in this gene, in view of it being part of a relevant pathway. No mutations were identified. No cases to link mutation to HPE in this gene at present, therefore considered red.Created: 30 May 2017, 4:04 p.m.
Lara Menzies (Great Ormond Street Hospital )
Mode of inheritance
Unknown
Phenotypes
Holoprosencephaly
Details
- Mode of Inheritance
- Unknown
- Sources
-
- NHS GMS
- Expert Review Red
- Radboud University Medical Center, Nijmegen
- Phenotypes
-
- Unknown
- OMIM
- 601366
- Clinvar variants
- Variants in SMAD2
- Penetrance
- Complete
- Publications
-
- (Roessler (2008) Am J Hum Genet 83,18) 18538293
- Panels with this gene
History Filter Activity
Added New Source
Louise Daugherty (Genomics England Curator)Source NHS GMS was added to SMAD2.
panel promoted to version 1
Helen Brittain (Genomics England Curator)Promoted to version one after review within the genomics England curation team.
Gene classified by Genomics England curator
Helen Brittain (Genomics England Curator)This gene has been classified as Red List (Low Evidence).
Set Phenotypes
Helen Brittain (Genomics England Curator)Phenotypes for SMAD2 were set to Unknown
Set publications
Helen Brittain (Genomics England Curator)Publications for SMAD2 were set to (Roessler (2008) Am J Hum Genet 83,18) 18538293
Created
Olivia Niblock (Genomics England Curator)SMAD2 was created by oniblock
Added New Source
Olivia Niblock (Genomics England Curator)SMAD2 was added to Holoprosencephalypanel. Sources: Radboud University Medical Center, Nijmegen